Anticavity Fluoride

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the prevention of dental cavities. It is intended for use in individuals at risk of developing dental caries.

Dosage and Administration

Adults and children aged 6 years and older are instructed to use the rinse once daily, following the brushing of their teeth with toothpaste. The recommended method involves vigorously swishing 10 milliliters of the rinse between the teeth for a duration of 1 minute, after which the solution should be expectorated. It is imperative that the rinse is not swallowed. Additionally, patients should refrain from eating or drinking for 30 minutes following the rinsing procedure to ensure optimal efficacy.

For children under 12 years of age, it is essential to instruct them in proper rinsing techniques to minimize the risk of swallowing the rinse. Supervision may be required until the child demonstrates the ability to use the rinse independently and safely.

For children under 6 years of age, consultation with a dentist or physician is recommended prior to use.

Contraindications

There are no specific contraindications listed for this product. However, it is advised that if more than the recommended amount used for rinsing is accidentally swallowed, immediate medical assistance should be sought or contact with a Poison Control Center (1-800-222-1222) should be made.

Warnings and Precautions

It is imperative to keep this product out of the reach of children to prevent accidental ingestion. In the event that more than the recommended amount used for rinsing is accidentally swallowed, immediate medical assistance should be sought. Healthcare professionals are advised to instruct patients to contact a Poison Control Center at 1-800-222-1222 without delay.

No specific general precautions or laboratory tests are required for the safe use of this product. However, vigilance is essential in monitoring for any adverse effects, particularly in cases of accidental ingestion.

Side Effects

In clinical use, patients should be aware of the potential for serious adverse reactions associated with accidental ingestion of the product. If more than the recommended amount for rinsing is swallowed, it is imperative to seek medical assistance immediately or contact a Poison Control Center at 1-800-222-1222. This warning underscores the importance of adhering to the prescribed usage to mitigate risks associated with overdose.

Healthcare professionals should educate patients on the proper use of the product to prevent such occurrences and ensure that they are informed about the necessary steps to take in the event of accidental ingestion.

Drug Interactions

There are currently no documented drug interactions associated with the use of this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Anticavity Fluoride (sodium fluoride). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients 6 years of age and older are instructed to use the rinse once daily after brushing their teeth with toothpaste. They should vigorously swish 10 milliliters of the rinse between their teeth for 1 minute before spitting it out. It is important that the rinse is not swallowed, and children should refrain from eating or drinking for 30 minutes following the rinse. Caregivers should instruct children under 12 years of age in proper rinsing techniques to minimize the risk of swallowing, and supervision is recommended until the child is capable of using the rinse independently.

For children under 6 years of age, consultation with a dentist or doctor is advised prior to use.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

The safety of sodium fluoride mouthwash during pregnancy has not been established, as the prescribing information does not provide specific data regarding its use in this population. Consequently, healthcare professionals should exercise caution when recommending this product to pregnant patients. There are no known safety concerns, dosage modifications, or special precautions outlined for the use of sodium fluoride mouthwash in pregnant women. Given the lack of information, it is advisable for women of childbearing potential to consult with their healthcare provider before using this mouthwash during pregnancy.

Lactation

There are no specific warnings or recommendations regarding the use of this product by lactating mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution and consider the lack of specific guidance when prescribing to patients with reduced kidney function.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If an individual accidentally swallows more than the amount intended for rinsing, it is imperative to seek medical help or contact a Poison Control Center at 1-800-222-1222 without delay.

Healthcare professionals should be aware that prompt intervention can significantly mitigate potential adverse effects associated with overdosage. Monitoring for symptoms and providing appropriate management based on clinical presentation is essential.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients that if more than the recommended amount used for rinsing is accidentally swallowed, it is important to seek medical help immediately or contact a Poison Control Center at 1-800-222-1222. This information is crucial for ensuring patient safety and prompt action in case of an emergency.

Storage and Handling

The product is supplied in configurations that include specific NDC numbers. It should be stored at room temperature to maintain its integrity and efficacy. Healthcare professionals are advised to ensure that the safety seal is intact before use; the product should not be utilized if the safety seal is broken or missing. Proper handling and storage conditions are essential to ensure the product remains safe and effective for patient use.

Additional Clinical Information

The product is administered via the dental route, with a recommended frequency of once daily for adults and children aged 6 years and older, following tooth brushing. Clinicians should instruct children under 12 years in proper rinsing techniques to minimize swallowing and supervise their use until they are capable of using the product independently.

No additional information is available regarding laboratory tests, abuse potential, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Anticavity Fluoride, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)